Covered transjugular intrahepatic portosystemic stent-shunt vs large volume paracentesis in patients with cirrhosis: A real-world propensity score-matched study

Table 5 Multivariable analysis of selected independent variables predicting transplant-free survival (whole cohort)

	B	SE	Wald	Df	P value	Hazard ratio	95%CI
Age	0.006	0.011	0.267	1	0.605	1.006	0.984-1.028
Albumin	-0.081	0.027	9.185	1	0.002	.923	0.876-0.972
Recurrent ascites	0.041	0.252	0.026	1	0.872	1.042	0.635-1.708
TIPSS	-0.219	0.303	0.521	1	0.471	0.804	0.444-1.456
HCC at baseline	-1.548	0.363	18.232	1	< 0.001	0.213	0.104-0.433
MELD	-0.033	.035	0.900	1	0.343	0.968	0.904-1.036
Sex (1 = male, 2 = female)	0.134	0.222	0.364	1	0.546	1.144	0.739-1.769
CPS	0.085	0.127	0.446	1	0.504	1.088	0.849-1.395
SBP	-0.054	0.264	0.042	1	0.837	0.947	0.565-1.589

B: Beta coefficient; SE: Standard error; Df: Discriminative function; CI: Confidence interval; TIPSS: Transjugular intrahepatic portosystemic stent shunt; HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; CPS: Childs Pugh score; SBP: Spontaneous bacterial peritonitis.